Patients who develop A-fib after TAVR are at a significantly increased risk of all-cause mortality at 30 days and 1 year when compared with those who remain in normal sinus rhythm following the ...
Patients who show evidence of new A-fib following noncardiac surgery are at the same long-term risk of thromboembolism as those with nonsurgical nonvalvular A-fib, according to new observational data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results